Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus
- PMID: 8341492
- DOI: 10.1016/s0161-6420(13)31517-6
Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus
Abstract
Background: The etiology of diabetic retinopathy is poorly understood. In the current study, factor associated with the onset and the progression or regression of retinopathy are evaluated.
Methods: Two hundred seventy-seven subjects with insulin-dependent (type I) diabetes mellitus (IDDM) were evaluated longitudinally for retinal changes over a mean of 2.7 years. The multistate Markov model was used to analyze the influences of the duration of diabetes, a family history of hypertension, age, sex, cigarette smoking, systolic blood pressure, diastolic blood pressure, cholesterol levels, and longitudinal glycohemoglobin (GHb) values on the development and the progression or regression of retinopathy.
Results: Univariate analysis confirmed that four factors were significantly associated with the etiology and the progression or regression of diabetic retinopathy: age, duration of diabetes, mean longitudinal GHb levels (all at P < 0.01), and diastolic blood pressure (P < 0.04). However, age was no longer significant when controlled by duration of diabetes. Cigarette smoking was only associated significantly with background retinopathy (stages 2 and 3). Systolic blood pressure, sex, a family history of hypertension, and cholesterol levels were not significantly associated with retinopathy.
Conclusions: The onset of diabetic retinopathy is associated with the duration of diabetes, mean longitudinal GHb levels, smoking, and diastolic blood pressure. A longer duration of diabetes, higher GHb values, and higher diastolic blood pressure levels are associated with an increased risk of progression and a decreased chance of regression of diabetic retinopathy.
Similar articles
-
The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis.Endocrine. 2018 Nov;62(2):299-306. doi: 10.1007/s12020-018-1697-y. Epub 2018 Aug 20. Endocrine. 2018. PMID: 30128962 Review.
-
Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study.Ophthalmology. 1993 Aug;100(8):1125-31; discussion 1131-2. doi: 10.1016/s0161-6420(93)31516-2. Ophthalmology. 1993. PMID: 8341491
-
Determinants of retinopathy progression in type 1 diabetes mellitus.Am J Med. 1999 Jul;107(1):45-51. doi: 10.1016/s0002-9343(99)00165-5. Am J Med. 1999. PMID: 10403352
-
Blood pressure and retinopathy in type I diabetes.Ophthalmology. 1990 Feb;97(2):155-9. doi: 10.1016/s0161-6420(90)32611-8. Ophthalmology. 1990. PMID: 2326002
-
Monitoring for retinopathy in children and adolescents with type 1 diabetes.Acta Paediatr Suppl. 1998 Oct;425:35-41. doi: 10.1111/j.1651-2227.1998.tb01250.x. Acta Paediatr Suppl. 1998. PMID: 9822192 Review.
Cited by
-
Effect of breathing 100% oxygen on retinal and optic nerve head capillary blood flow in smokers and non-smokers.Br J Ophthalmol. 1997 May;81(5):365-9. doi: 10.1136/bjo.81.5.365. Br J Ophthalmol. 1997. PMID: 9227200 Free PMC article.
-
Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study.BMJ. 2008 Aug 26;337:a918. doi: 10.1136/bmj.a918. BMJ. 2008. PMID: 18728082 Free PMC article.
-
Effect of systemic medications on onset and progression of diabetic retinopathy.Nat Rev Endocrinol. 2010 Sep;6(9):494-508. doi: 10.1038/nrendo.2010.122. Epub 2010 Jul 27. Nat Rev Endocrinol. 2010. PMID: 20664533 Review.
-
The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis.Endocrine. 2018 Nov;62(2):299-306. doi: 10.1007/s12020-018-1697-y. Epub 2018 Aug 20. Endocrine. 2018. PMID: 30128962 Review.
-
Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.BMJ Open. 2019 Jun 17;9(6):e025788. doi: 10.1136/bmjopen-2018-025788. BMJ Open. 2019. PMID: 31213445 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical